Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Diagnostic value of the ovarian adnexal reporting and data system ultrasound in ovarian masses: a 2-center study.

The British journal of radiology·2024
Same author

Exploring the pathogenesis of depression and potential antidepressants through the integration of reverse network pharmacology, molecular docking, and molecular dynamics.

Medicine·2023
Same author

Rainfall Runoff and Flood Simulations for Hurricane Impacts on Woonasquatucket River, USA.

International journal of structural and civil engineering research·2023
Same author

Containment control of multiple unmanned surface vessels with NN control via reconfigurable hierarchical topology.

Frontiers in computational neuroscience·2023
Same author

Zhi Zi Chi decoction (Gardeniae fructus and semen Sojae Praeparatum) attenuates anxious depression via modulating microbiota-gut-brain axis in corticosterone combined with chronic restraint stress-induced mice.

CNS neuroscience & therapeutics·2023
Same author

Cross-cohort single-nucleotide-variant profiling of gut microbiota suggests a novel gut-health assessment approach.

mSystems·2023

Related Experiment Video

Updated: Jul 17, 2026

Surface-enhanced Resonance Raman Scattering Nanoprobe Ratiometry for Detecting Microscopic Ovarian Cancer via Folate Receptor Targeting
07:54

Surface-enhanced Resonance Raman Scattering Nanoprobe Ratiometry for Detecting Microscopic Ovarian Cancer via Folate Receptor Targeting

Published on: March 25, 2019

8.1K

Identifying macrophage-associated subtypes in patients with serous ovarian cancer and exploring potential

Fei Teng1,2, Hong Wei1, Dehong Che3

  • 1In-Patient Ultrasound Department, The Second Affiliated Hospital of Harbin Medical University, Harbin, China.

Heliyon
|March 3, 2025
PubMed
Summary

This study identifies M1 and M2 macrophage markers linked to chemotherapy drug sensitivity. Potential new treatments like dasatinib and afatinib were found for ovarian cancer.

Keywords:
ChemotherapyMacrophageMarkerSerous ovarian cancerWeighted gene co-expression network analysis

More Related Videos

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts
10:27

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Published on: July 25, 2020

7.2K
Author Spotlight: Exploring Strategies for Successful Immune Response Against Tumors
05:58

Author Spotlight: Exploring Strategies for Successful Immune Response Against Tumors

Published on: August 16, 2024

2.6K

Related Experiment Videos

Last Updated: Jul 17, 2026

Surface-enhanced Resonance Raman Scattering Nanoprobe Ratiometry for Detecting Microscopic Ovarian Cancer via Folate Receptor Targeting
07:54

Surface-enhanced Resonance Raman Scattering Nanoprobe Ratiometry for Detecting Microscopic Ovarian Cancer via Folate Receptor Targeting

Published on: March 25, 2019

8.1K
Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts
10:27

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Published on: July 25, 2020

7.2K
Author Spotlight: Exploring Strategies for Successful Immune Response Against Tumors
05:58

Author Spotlight: Exploring Strategies for Successful Immune Response Against Tumors

Published on: August 16, 2024

2.6K

Area of Science:

  • Oncology
  • Immunology
  • Genomics

Background:

  • Macrophage heterogeneity influences cancer progression and treatment response.
  • Identifying specific macrophage markers is crucial for targeted therapies.

Purpose of the Study:

  • To identify novel macrophage markers associated with chemotherapy drug sensitivity.
  • To explore potential therapeutic targets for personalized cancer treatment.

Main Methods:

  • Single-cell gene expression analysis and weighted gene co-expression network (WGCN) construction.
  • Development of a multi-factor regulatory network to identify macrophage subtypes.
  • Machine learning for marker filtering, drug sensitivity prediction, and therapeutic compound screening.

Main Results:

  • Identified 14 M1 and 17 M2 macrophage candidate markers.
  • Constructed regulatory networks revealing transcription factor and microRNA interactions.
  • Filtered 15 M1/M2 specific markers associated with chemotherapy drug sensitivity.

Conclusions:

  • Specific M1 and M2 macrophage markers were identified.
  • Potential therapeutic compounds, dasatinib and afatinib, were found for these markers.
  • Findings offer insights into ovarian cancer mechanisms and inspire novel treatment strategies.